Addex Therapeutics Files 6-K, Incorporates Exhibits
Ticker: ADXN · Form: 6-K · Filed: Jun 20, 2025 · CIK: 1574232
Sentiment: neutral
Topics: filing, registration-statement, incorporation-by-reference
Related Tickers: ADXN
TL;DR
Addex Therapeutics (ADXN) filed a 6-K, incorporating exhibits into its F-3 and S-8 filings. Likely related to stock or financing.
AI Summary
Addex Therapeutics Ltd. filed a Form 6-K on June 20, 2025, incorporating by reference Exhibits 99.1 and 99.2 into its existing registration statements on Form F-3 (Registration No. 333-255089) and Form S-8 (Registration Nos. 333-255124 and 333-272515). The company is a foreign private issuer based in Geneva, Switzerland.
Why It Matters
This filing indicates that Addex Therapeutics is updating or supplementing its existing registration statements, which could be related to ongoing financing activities, stock offerings, or employee stock plans.
Risk Assessment
Risk Level: low — This is a routine filing to incorporate exhibits into existing registration statements and does not appear to contain new material financial or operational information.
Key Players & Entities
- Addex Therapeutics Ltd. (company) — Registrant
- 333-255089 (dollar_amount) — Form F-3 Registration Number
- 333-255124 (dollar_amount) — Form S-8 Registration Number
- 333-272515 (dollar_amount) — Form S-8 Registration Number
FAQ
What is the purpose of incorporating Exhibits 99.1 and 99.2 into the registration statements?
The filing states that Exhibits 99.1 and 99.2 are incorporated by reference into the registration statements on Form F-3 and Form S-8, suggesting they contain information relevant to those filings, such as prospectus supplements or plan details.
What are the registration numbers mentioned in the filing?
The filing mentions Registration No. 333-255089 for Form F-3, and Registration Nos. 333-255124 and 333-272515 for Form S-8.
What type of company is Addex Therapeutics Ltd. based on the filing?
Addex Therapeutics Ltd. is identified as a foreign private issuer and its Standard Industrial Classification is Pharmaceutical Preparations [2834].
Where is Addex Therapeutics Ltd. headquartered?
Addex Therapeutics Ltd. is headquartered in Geneva, Switzerland, with its principal executive offices located at Chemin des Mines 9, CH-1202 Geneva.
What is the filing date and period of report for this 6-K?
This Form 6-K was filed on June 20, 2025, and the conformed period of report is also June 20, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 20, 2025 regarding Addex Therapeutics Ltd. (ADXN).